Skip to main content
OpenTrials
Completed

NCT Number: NCT01173575

Assessment of the Efficacy of FOSFOMYCIN in Patients With Bacterial Infection

This project aims to assess the clinical and microbiological efficacy of fosfomycin(FOM) in patients with bacterial infection.

Primary objective:

• To assess clinical and microbiological efficacy of FOM in patients with bacterial infection.

Secondary objectives:

* To determine the rate and severity of unexpected adverse events. * To determine the mean duration of therapy with FOM in patients with bacterial infection.

Study design:

Multi-center, non-interventional study

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Medical University Graz, Graz, Styria, Austria

Loading trial locations.

About this study

Please note that InfectoPharm Arzneimittel und Consilium GmbH has taken over sponsor responsibilities for all German sites of this clinical trial with Jannuary 2016 from J&P MEDICAL RESEARCH LTD.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with bacterial infection receiving FOM for clinical purposes will be included into the analysis.

Exclusion criteria

-

Sponsors and collaborators

Lead sponsor

Infectopharm Arzneimittel GmbH

Industry

Collaborators

  • J&P Medical Research Ltd.
  • Sandoz GmbH

Registry information

Important dates

Study start
2010
Primary completion
2016
Study completion
2016
First posted
Aug 2, 2010
Registry last updated
Jul 2, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.